Palantir Technologies

Palantir continues its rapid growth and expects revenue of roughly $2.65 billion for the current quarter, about a 90% rise year over year. Last quarter revenue already grew 96% to $2.3 billion and quarterly profit rose 49% to $1.13 billion. The US business is the main driver with revenues of $1.94 billion; the government segment grew 96% to $953 million, and the commercial business grew 148% to $984 million. The UK signed a billion-dollar contract, and a nationwide deployment is also being considered in Germany, while critics warn of privacy and power concerns. » More on heise.de

Palantir reports strong growth again: in the third quarter revenue rose to $2.3 billion and quarterly profit to $1.13 billion. For the current quarter the company forecasts about $2.65 billion in revenue, an increase of roughly 90% year on year. The growth is driven mainly by the US market, with US revenues climbing to $1.94 billion, including $953 million from government contracts and $984 million from commercial business. Investors remain cautious due to a possible slowdown and broader AI market worries; the stock was last about 4.7% below the US closing price. » More on manager-magazin.de

Palantir reported $2.31 billion in revenue for the third quarter, an adjusted operating margin of 62 percent, and raised its full-year guidance to about $8.53 billion. Its US commercial business grew markedly and for the first time exceeded government revenue; Q4 guidance is $2.65 billion. CEO Alex Karp thanked retail investors for their support and said those who had mocked the company 'must suffer for it'. » More on deraktionaer.de

Palantir reported Q3 adjusted EPS of $0.44 and revenue of $2.31 billion, beating estimates as revenue nearly doubled year‑over‑year. U.S. commercial revenue rose 148% to $984 million, exceeding U.S. government revenue of $953 million. Net income more than doubled to $1.13 billion. The company raised its U.S. commercial revenue guidance to above $3.56 billion and expects about $2.65 billion in Q4 and $8.53 billion for full‑year 2026. » More on cnbc.com

Freedom of information responses show 29 NHS trusts that NHS England lists as "realising benefits" from Palantir's federated data platform say the system is not live or its applications are not being used. The discrepancy has prompted criticism from MPs and campaigners, calls to activate a break clause in the contract, and an investigation by the statistics watchdog into NHS claims. Palantir and NHS England maintain the platform delivers benefits and point to national usage metrics, while critics demand clearer, verifiable reporting of results. » More on theguardian.com